Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Nortriptyline
100%
Antidepressant
75%
High-Content Screening
50%
Recurrence Risk
50%
Placebo
50%
Lithium Carbonate
25%
Monotherapy
25%
Major Depression
25%
Depression
25%
Clinical Feature
25%
Medicine and Dentistry
Electroconvulsive Therapy
100%
Drug Therapy
100%
Nortriptyline
26%
Antidepressant
13%
Recurrence Risk
13%
Placebo
13%
Relapse Prevention
13%
Antidepressant Medication
6%
Monotherapy
6%
Clinical Feature
6%
Major Depressive Episode
6%
Depression
6%
Lithium Carbonate
6%
Neuroscience
Electroconvulsive Therapy
100%
Nortriptyline
26%
Antidepressant
20%
Relapse Prevention
13%
Placebo
13%
Lithium Carbonate
6%
Major Depressive Disorder
6%
Depression
6%